Lv61
2930 积分 2023-12-20 加入
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
11天前
已完结
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
11天前
已完结
Gemtuzumab ozogamicin in acute myeloid leukemia
14天前
已完结
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
14天前
已完结
Tozorakimab to Prevent COPD Exacerbations
19天前
已完结
Efficacy and Safety of Mepolizumab in Eosinophilic COPD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
19天前
已完结
Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions
19天前
已完结
Discovery and development of bispecific antibodies
19天前
已完结
Structural basis of human U5 snRNP late biogenesis and recycling
21天前
已完结
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
22天前
已完结
皖公网安备34019202002308
